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Abstract
Background: Bovine herpesvirus 5 (BoHV-5) is an alphaherpesvirus responsible for meningoencephalitis in young
cattle and it is antigenically and genetically related to bovine herpesvirus 1. BoHV-5 outbreaks are sporadic and
restricted in their geographical distribution, being mostly detected in the Southern hemisphere. The N569 and
A663 strains are prototypes of the “a” and “b” subtypes of BoHV-5, however, scarce information about their in vitro
and in vivo properties is currently available.
Methods: For the in vitro comparison between BoHV-5 A663 and N569 strains, viral growth kinetics, lysis and
infection plaque size assays were performed. Additionally, an experimental infection of cattle with BoHV-5 A663
and N569 strains was carried out. Viral excretion, development of neurological signs, presence of specific antibodies
in serum and nasal swabs and presence of latent BoHV-5 DNA in trigeminal ganglion, were analyzed.
Histopathological examination of samples belonging to inoculated animals was also performed.
Results: The lytic capacity and the cell-to-cell spread was lower for the A663 strain compared to the N569 strain,
however, the production of total infectious viral particles was similar between both strains. Concerning the in vivo
properties, the A663 and N569 strains are able to induce similar degrees of pathogenicity in cattle.
Conclusions: Our results show that the A663 strain used in this study is less adapted to in vitro replication in
MDBK cells than the N569 strain and, although slight differences were observed, both strains are able to induce a
similar degree of virulence in the natural host.
Background
Bovine herpesvirus 5 (BoHV-5) is an alphaherpesvirus
associated with meningoencephalitis in young cattle and
it is antigenically and genetically related to bovine her-
pesvirus 1 (BoHV-1) [1-3]. BoHV-5 was former classi-
fied as a neuropathogenic variant of BoHV-1. In 1992,
data based on restriction site mapping of viral DNA
[4-6], cross-neutralization tests, and monoclonal anti-
body reactivity [7,8], allowed the International Commit-
t e eo nT a x o n o m yo fV i r u s e st or e c o g n i z eB o H V - 5a sa
distinct virus from BoHV-1 [9].
Contrasting with the BoHV-1 worldwide distribution,
BoHV-5 outbreaks are sporadic and restricted in their
geographical distribution, being mostly detected in the
Southern hemisphere. The reasons for this particular
distribution are still undetermined. Sporadic cases of
BoHV-5-associated encephalitis have been detected in
Australia [10,11], North America [4,12] and Europe
[13,14]. Outbreaks are most commonly reported in Bra-
zil [15-17] and Argentina [18-20].
According to restriction endonuclease analysis, BoHV-
5 strains are classified into three subtypes [8,21]. Type
strains for subtypes “a”, “b” and “non-a-non-b”,a r et h e
Australian strain N569, the Argentinean strain A663
and Brazilian isolates, respectively. Despite the geogra-
phical proximity between Argentina and Brazil, most of
the Brazilian isolates studied belong to the “a” subtype
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any medium, provided the original work is properly cited.[21]. This discrepancy could be attributed to the small
number of BoHV-5 isolates characterized to date in
Argentina and Brazil. Besides, the isolates examined to
date may not be actual representatives for the most pre-
valent viruses in Brazil, as well as A663 itself may not
be a typical representative of most Argentinean BoHV-5
isolates currently circulating in this country. In line with
this, recent analysis of Argentinean BoHV-5 isolates iso-
lated from 1982 to 2007 revealed that the “a” subtype is
the most prevalent in this country [22]. Further charac-
terization of recently isolated BoHV-5 field strains from
Argentina and Brazil will provide information about the
subtypes currently circulating in these countries.
BoHV-5 infection induces different degrees of severity
of neurological disease depending on both viral and host
factors. Viral genes and their encoded proteins involved
in the neurovirulence of alphaherpesviruses are classified
in three groups: enzymes involved in nucleic acid meta-
bolism, factors that modulate the immune response and
viral glycoproteins (g). Regarding viral glycoproteins, a
role in the anterograde transport of gI, gE and Us9 was
suggested in the rabbit model [23,24]. Concerning host
factors, the age and immunological status of the animals
appear to be the most relevant ones [25].
Scarce in vitro s t u d i e st oa s s e s st h eg r o w t hp r o p e r -
ties of N569 and A663 strains have been performed.
These studies allowed the identification of cell lines
susceptible to BoHV-5 [10] and the establishment of
growth curves [19]. Concerning in vivo properties,
some experimental inoculations with BoHV-5 N569
and A663 strains have been carried out [8,26-28]. In
these studies, neurological signs, such as bruxism,
depression, anorexia and muscle trembling, were
observed in calves infected with both BoHV-5 strains.
Although BoHV-5-induced encephalitis is usually fatal
in young animals, some experimentally infected calves
develop subclinical infection [25,29,30] or moderate
d i s e a s e[ 2 7 ] .H o w e v e r ,u pt on o w ,t h ein vivo studies
of N569 and A663 strains were independently per-
formed and carried out under different conditions. At
this point, a direct comparison of the pathogenecity of
these strains is difficult to make.
In this context, the aim of the present study is to
compare the in vitro and in vivo properties of these two
BoHV-5 reference strains belonging to different
subtypes.
Materials and methods
Viruses and cell culture
The N569 BoHV-5 strain was isolated from a brain
sample after several intracerebral inoculations of calves
with brain tissue obtained from an outbreak of menin-
goencephalitis in calves reported in 1962 in Australia
[10]. The A663 BoHV-5 strain was isolated from a case
of non purulent encephalitis in an outbreak among
calves in 1982 in Argentina [19].
N569 and A663 BoHV-5 strains were propagated in
Madin Darby bovine kidney (MDBK) cells and viral
stocks were produced after infection of MDBK at a low
multiplicity of infection (MOI) as previously described
[31].
Viral growth kinetic
To perform one-step kinetics, MDBK monolayers grown
in 60 mm culture dishes were inoculated with BoHV-5
N569 or A663 at MOI 5. Cells were incubated at 4°C
for 2 h in order to synchronize virus adsorption. Then,
cells were incubated at 37°C for 2 h and treated with
low pH solution (40 mM citric acid, 10 mM KCl, 135
mM NaCl) for 2 min to inactivate the remaining extra-
cellular virus. Monolayers were rinsed with PBS, E-
MEM 2% FCS was added and the dishes were incubated
at 37°C. At 0; 3; 6; 12; 15; 18 and 24 h post infection
(hpi) the extracellular and total fractions were obtained.
These fractions were titrated twice on MDBK mono-
layers in duplicate and viral titres were calculated by the
Reed and Muench method [31]. Mean of viral titres
were compared by Mann-Whitney no-parametric test,
P<0 . 0 5( S o f t w a r eM e d C a l c
® statistical software version
11.1.1.0).
Lysis and infection plaque size assays
MDBK monolayers grown in 12 wells culture plates
were inoculated with BoHV-5 N569 or A663 at tenfold
serial dilutions. After 2 h of incubation at 37°C, the
inoculum was removed and 2 ml of carboxy methyl cel-
lulose (CMC) 1.5% FCS per well were added. Plates
were incubated at 37°C for 72 h.
For the lysis plaque size assay, cells were fixed with
10% formaldehyde for 10 min at room temperature,
stained with violet crystal (1% violet crystal, 10% ethanol
in PBS) for 20 min and washed in PBS. For each virus,
60 isolated and randomly selected lysis plaques were
observed with an optical microscope and photographed.
For the infection plaque size assay, cells were fixed
with 4% paraformaldehyde (PFA) for 10 min at room
temperature. After washing in PBS, cells were incubated
for 1 h at 37°C with an anti IBR-FIT-C conjugated anti-
body (VMRD, Inc. Pullman, U.S.A) diluted in PBS and
then cells were washed twice in PBS. For each virus, 30
isolated and randomly selected infectious foci were
observed with a fluorescent microscope and
photographed.
The photographs were analyzed with ImageJ software
in order to calculate lysis and infection plaques surfaces.
Animal experimental design
Ten 3-month-old calves were housed in an experimental
unit two weeks before infection. Upon arrival and before
Ladelfa et al. Acta Veterinaria Scandinavica 2011, 53:37
http://www.actavetscand.com/content/53/1/37
Page 2 of 8experimental infection, their naïve status for BoHV-1
and 5 exposures were verified by ELISA, seroneutraliza-
tion and lack of viral isolation from nasal swabs. Calves
were separated in 2 groups of four animals each and
one group of two animals (control group, uninfected
animals). The groups were strictly isolated from each
other during the course of the study in order to avoid
viral spread and contamination. Animal care and experi-
mental procedures were performed in accordance with
the requirements of the National Institute of Agricul-
tural Technology Ethics Committee (INTA, Argentina).
Two groups were infected by aerosolization with 3 ml
of E-MEM containing a total dose of 10
6.5 TCID50/ml
(1.5 ml in each nostril) of N569 or A663 BoHV-5
strains. Control group received 3 ml of E-MEM. Clinical
observation of respiratory and nervous signs, and rectal
temperature were recorded in an individual sheet for
each animal. Between days 35-37 post infection (pi) ani-
mals were sedated with acepromazine (Asedan, Holliday
Laboratories, San Isidro, Argentina) by intramuscular
route and then euthanized by a barbiturate overdose
(Euthanyle, Brouwer Laboratories, Ciudad Autónoma de
Buenos Aires, Argentina). One animal from the BoHV-5
A663 group developed severe neurological signs and
was euthanized at day 15 pi. For all animals, necropsy
was performed immediately after euthanasia. Transverse
sections from the cervical spinal cord, olfactory cortex,
frontal, parietal and occipital cortex, thalamus, mesence-
phalon, cerebellum, trigeminal ganglia and respiratory
tract tissues were collected. To perform histological
examination, the samples were fixed in 10% neutral buf-
fered formalin, prepared by routine methods for histol-
ogy, paraffin embedded, sectioned at 4 μma n ds t a i n e d
with hematoxylin and eosin. The histopathological CNS
alterations were interpreted as follows: +++: severe; ++:
moderate; +: slight; -: none.
Sampling procedure, serological and virological analysis
Blood samples were taken on the day of inoculation and
then weekly by jugular venipuncture to monitor anti-
body levels. Sera obtained after centrifugation were
stored at -20°C until analyzed. Serum antibodies against
BoHV-1 and -5 were detected by ELISA and seroneutra-
lization [31].
Nasal secretions were collected inserting tampons in
the ventral meatus of the nasal cavity for 5 min (to
assure the absorption of nasal fluids potentially con-
taining viral particles into the tampon) and thereafter
immediately dipped in 5 ml E-MEM containing 5000
IU penicillin/ml, 2500 μg streptomycin/ml and 10 μg
amphotericin B/ml [31]. Tampons were centrifuged
and samples were stored at -80°C until used. Nasal
samples were taken daily from day 0 to 18 pi and
then two times per week until the end of the study.
Nasal swabs were inoculated immediately after collec-
tion onto MDBK cell monolayers: 0.1 ml of nasal
fluids was inoculated onto 96 well microtitre plates
and tenfold serial dilutions were tested in four wells.
Monolayers were inspected until cytopathic effect
appeared and virus titres were calculated by the Reed
and Muench method [32]. IgA antibodies in nasal
secretions were determined by ELISA as previously
described [27].
Detection of latent BoHV-5 DNA in trigeminal ganglion
Pieces of approximately 100 mg of trigeminal ganglion
were digested and total DNA extracted using the
QIAamp DNA Mini kit (Qiagen, Spain). In order to
examine the presence of viral DNA, a polymerase chain
reaction (PCR) that amplifies BoHV-5 gD gene was per-
formed [33]. PCR was also performed with a set of pri-
mers generating a 250 base pair fragment from the
bovine glyceraldehyde-3-phosphate dehydrogenase gene
(GAPDH), selected as bovine housekeeping gene. The
primers were designated as GAPDH-Fow (5’-GCA TCG
TGG AGG GAC TTA TGA) and GAPDH-Rev (5’-GGG
CCA TCC ACA GTC TTC TG).
Results
In vitro characterization
With the aim of performing an in vitro comparison
between N569 and A663 BoHV-5 strains, their growth
properties, lysis and infection plaque size were assessed.
The one-step growth kinetics curves profiles for the
N569 and A663 strains of BoHV-5 were established.
Total fractions curves showed similar profiles and the
amount of infectious virus produced was also similar
between both strains at each time assayed (Figure 1A).
Significant differences between A663 and N569 viral
titres in their total fractions at each time assayed were
not found. Maximum titres were obtained at 24 (10
6.8
TCID50/ml) and 18 (10
7.0 TCID50/ml) hpi for N569 and
A663, respectively.
As shown in Figure 1B, the release of infective viral
particles to the extracellular media was first detected for
A663 strain (at 6 hpi). However, the viral titre reached
by this strain from 15 to 24 hpi was slightly lower than
the titre reached by N569 strain. Although significant
differences between N569 and A663 viral titres were
observed at 15 and 18 hpi, at the end of the assay (24
hpi) both strains showed similar viral titres in their
extracellular fractions.
In order to study the lytic capacity of both BoHV-5
strains, the lysis plaque size assay was performed. This
parameter contributes to the in vitro characterization of
viruses because it represents a direct measure of viral
lytic potential and an indirect measure of viral cell-to-
cell spread.
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inoculation of MDBK monolayers with the N569 and
A663 strains, shown a sharp difference, being the pla-
ques generated by the A663 strain 90% smaller than
those generated by the N569 strain (Figure 2). This
result is in agreement with the lower viral titres
observed in the extracellular fraction of the one-step
growth kinetics of the A663 strain in comparison with
those of the N569 strain.
To further analyze the cell-to-cell spread of the N569
and A663 strains, the infection plaque size assay was
performed. This assay takes into consideration the cells
lysed by the virus and also the infected cells expressing
viral antigens on their surface, being therefore an appro-
priate tool for studying cell-to-cell dissemination.
The comparison between the infection plaques gener-
ated by N569 and A663 strains showed a sharp differ-
ence, being the plaques generated by the A663 strain
80% smaller than those generated by the N569 strain
(Figure 3).
In vivo characterization
In order to perform an in vivo comparative study of the
reference BoHV-5 strains, two groups of 4 calves were
infected with N569 (subtype “a”)o rA 6 6 3( s u b t y p e“b”)
strains. A mock infected group of two animals was
included (control group).
After intranasal infection, both groups showed a simi-
lar time period of viral excretion (14 days). Three out of
four animals infected with N569 strain presented viral
particles in nasal swabs, one of them showing an inter-
mittent profile of viral excretion (Table 1). All the ani-
mals infected with A663 strain shed virus, three of them
excreted during 5-13 days and the remaining one
showed intermittent excretion (Table 1). The profiles of
viral shedding were similar between both groups in the
studied period. Control animals did not excrete virus
during the studied period.
Clinical signs associated with BoHV-5 infection were
observed in one A663 infected calf. This animal showed
breathing difficulties and a slight ptyalism at day 11 pi.
Nervous signs started day 12 pi and were characterized by
bruxism, ptyalism, muscular tremor, circular movements,
ataxia and seizure-like episodes. At day 15 pi this animal
was euthanized according to ethical considerations. None
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Figure 1 One-step growth kinetics of bovine herpesvirus-5
N569 and A663 strains (MOI 5). A: total fraction viral titres. B:
extracellular fraction viral titres. Viral titres are expresed as Log10
TCID50/ml. * N569 and A663 are significantly different (Mann-
Whitney, P < 0.05).
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Figure 2 Lysis plaques generated by bovine herpesvirus-5
A663 (A) and N569 (B) strains. Magnification Obj. 40×. C: Size rate
between both strains. The N569 mean area was established as
100%. Error bars represent standard deviation. N569 and A663 are
significantly different (Mann-Whitney, P < 0.01).
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Figure 3 Infection plaques generated by bovine herpesvirus-5
A663 (A) and N569 (B) strains. Magnification Obj. 40×. C: Size rate
between both strains. The N569 mean area was established as
100%. Error bars represent standard deviation. N569 and A663 are
significantly different (Mann-Whitney, P < 0.01).
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oped nervous signs during the studied period. At days 35-
36 pi the surviving animals were sacrificed and necropsy
was performed.
Histopathological examination of samples belonging to
BoHV-5 N569 and A663 groups revealed the presence
of severe lesions in the CNS associated with BoHV-5
infection in two out of four animals in each group.
These animals presented non suppurative meningoence-
phalitis in the olfactory cortex, frontal, parietal and occi-
pital cortex, thalamus, mesencephalon and cerebellum.
Focal gliosis was also found. Mild infiltration by macro-
phages in the mesencephalon, thalamus, cerebellum and
spinal cord were observed. The other two animals from
BoHV-5 A663 strain group showed moderate or slight
lesions in all sections examined meanwhile the other
two animals infected with N569 did not show significant
alterations in the CNS (Table 2).
Next, the establishment of latency of both BoHV-5
strains was examined. In order to test the presence of
latent BoHV-5 DNA, PCR assays were performed using
samples from trigeminal ganglia dissected after euthana-
sia. Viral DNA was detected in all animals from A663
group and in two animals from N569 group (Table 2).
In addition, trigeminal ganglia were assessed for induc-
tion of cytopathic effect in susceptible cells. Since no
cytopathic effect was developed in the cultures, we con-
cluded that the positive PCR results were due to the
presence of latent viral genomes.
With a view to evaluating seroconversion specifically
raised against BoHV-5 after the experimental infection,
serum antibodies and mucosal IgA were analysed.
Serum antibodies either measured by ELISA or by SN
assay were detected in seven out of eight BoHV-5
infected animals. Moreover, we detected nasal IgA in
five out of eight infected animals (Table 2).
Discussion
T h er e a lp r e v a l e n c eo fB o H V - 5i su n k n o w nb e c a u s e
outbreaks are sporadic and routine serologic tests do
Table 1 Viral titres shedding after experimental infection of calves (n = 8) with N569 and A663 strains of bovine
herpesvirus (BoHV)-5
Grupo Animal no. Days post infection
2 3 4 5 6 7 8 9 1 01 11 21 31 41 5
BoHV-5 N569 628 Nd Nd Nd Nd Nd 2 Nd 5 Nd 3.5 3.5 3.5 3.3 2.5
191 Nd Nd Nd Nd Nd Nd Nd Nd Nd Nd Nd Nd Nd Nd
199 1.6 4.3 Nd Nd 3.3 Nd Nd Nd Nd Nd Nd Nd Nd Nd
636 2.6 Nd 5 5.3 Nd 4.3 6 3 4.5 Nd 3 Nd Nd Nd
BoHV-5 A663 254 3 2.3 5 4.5 4.5 5 3.5 Nd 3.5 1.6 3.3 Nd Nd 2
619 3.6 5.3 5.5 5.5 5 N dN dN dN dN dN dN dN dN d
192 3.5 4 4.6 5.3 6 6.5 6.3 5 5.3 3.5 3.5 2 1.6 Nd
185 Nd Nd 2.5 Nd Nd Nd Nd Nd Nd 2.3 2 Nd Nd Nd
Nd: Non detected
Titres are expressed as log TCID50/ml of nasal secretions. For each animal, the peak titer of viral excretion is highlighted in bold.
Table 2 Data obtained from calves (n = 8) experimentally inoculated with A663 and N569 strains of bovine
herpesvirus (BoHV) 5
Group Animal
no.
Viral excretion* (peak
titre)
Severity of histopathological changes
(mean)**
DNA in
TG
SN Abs titre(log)
***
Nasal
IgA
BoHV-5
N569
636 2-12 (6) +++ + 1.5 +
628 7-15 (5) ++ + 1.05 -
199 Intermittent (4.3) - - 1.5 +
191 - - - - -
BoHV-5
A663
192 2-12 (6.5) +++ + 0.9**** -
619 2-6 (5.5) +++ + 0.9 +
185 Intermittent (2.3) + + 0.9 +
254 2-12 (6.3) + + 0.9 +
*Viral excretion is expressed as log TCID50/ml. **Score based on the presence of the following CNS histopathological alterations: vascular alteration, inflammation,
focal gliosis, infiltration by macrophages and malacia. References: +++: severe; ++: moderate; +: slight; -:negative. ***Serum neutralizing (SN) antibodies (Abs) at
day 34 post infection (pi). ****Animal 192 was euthanized 15 days pi, the titre of SN Abs corresponds to this date.
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and BoHV-1. Due to that, BoHV-5 sanitary and eco-
nomic impact may be underestimated. This, in addition
to the scarce information available on BoHV-5 biology,
has prompted the present study.
The in vitro characterization performed here suggests
that the A663 strain (BoHV-5 subtype “b”) possesses
diminished capacities concerning cell lysis and cell-to-
cell spread in comparison with the N569 strain (BoHV-
5s u b t y p e“a”). In addition, the in vivo properties of
A663 and N569 were analyzed and, as a result, we
observed that both BoHV-5 strains induced a similar
degree of virulence in cattle.
Regarding the in vitro characterization, the results
obtained from the one-step growth kinetic showed that
the production of total infectious viral particles was
similar between both BoHV-5 strains. However, the
release of infectious viral particles to the extracellular
m e d i aw a sl o w e rf o rt h eA 6 6 3s t r a i n .T h eo n e - s t e p
growth kinetic was performed at high MOI, thus, all
cells were infected and cell-to-cell spread was not being
evaluated. Hence, the lower release of A663 infectious
viral particles to the extracellular media suggested a
lower lytic capacity for this strain. This suggestion was
directly confirmed by the lysis plaque size assay, which
showed that lysis plaques generated by A663 were 90%
smaller than those generated by N569. Indeed, this dra-
matic difference led us to suggest that the A663 strain
has a less effective cell-to-cell spread in comparison
with N569. In this respect, multiple-steps growth kinetic
(performed at low MOI) showedt h ev i r a lt i t r e si nb o t h
extracellular and total fractions were larger for N569
than for A663, supporting the contribution of cell-to-
cell spread to the lysis plaque area reduction observed
for the A663 strain (data not shown). To further assess
this, the infection plaque size assay was performed and
showed that A663 plaques were 80% smaller than those
generated by N569 strain. In this context, we concluded
that both lytic capacity and cell-to-cell spread are dimin-
ished in the A663 strain in comparison with N569. The
fact that A663 and N569 reach the same viral titres in
their total fractions in the one-step growth kinetics
(from 3 to 24 hpi) indicates that viral particles are
equally produced by both strains, however, A663 viral
particles could be retained for longer times inside the
cell due to their difficulties in cell-to-cell spread and cell
lysis.
Some aspects of the in vitro viral replication discussed
here could have some relevance in vivo, for example: i)
in vitro total production of infectious virus could be
related with in vivo levels of viral excretion, or ii) in
vitro cell-to-cell spread could have consequences on
viral dissemination and infection of different animal tis-
sues, or iii) the lytic capacity could be associated with
the level of tissues damage and therefore with the clini-
cal signs observed after viral infection. All these correla-
tions could help understanding the fact that “b” subtype
of BoHV-5 has only been reported in Argentina [21,34]
and that it seems to have disappeared since it has not
been found circulating during the last years [22]. As
suggested by our in vitro results, A663 strain could have
diminished capacities to be maintained in the cattle
population, in contrast with “a” subtypes of BoHV-5,
which circulation among Argentinean cattle herds have
been recently reported for first time [22].
The differences observed in the lysis and the infection
plaque sizes between both BoHV-5 strains are larger
than expected and have not been reported for wild type
strains of the same alphaherpesvirus previously. Despite
the fact that the viruses used to perform these assays
had the same number of cell culture passages (n = 8),
t h ep r e v i o u sp a s s a g e st ot h i se x p e r i e n c eo nt h eo r i g i n a l
viral stocks were unknown. In our work, passage 8 of
N569 strain was obtained after successive passages in
cell culture from virus excreted by an animal infected
with a N569 virus of unknown, and thus high, number
of passages. For this strain, no difference in lysis plaque
size was observed between passage 8 and the virus of
high number of passages used to infect the bovine (data
not shown). Concerning A663 strain, passage 8 of A663
strain was also obtained after successive passages in cell
culture from virus secreted by an animal infected with
this strain, but in this case, the strain used to infect the
animal had a low number of passages. Contrary to
N569, a sharp difference between A663 passage 8 and
A663 of high number of passages was observed in lysis
plaque size, being those caused by A663 passage 8
much smaller. This indicates that plaque size increased
with the number of passages in cell culture of the non-
adapted to cell culture A663 strain (data not shown).
Taking all this into consideration, we are not able to
exclude differences between both strains strictly due to
cell culture adaptation. Additionally, the genetic back-
ground of N569 and A663 strains is unknown and we
are not able to rule out the possibility of genomic differ-
ences having an impact on the in vitro behavior of both
BoHV-5 strains.
Concerning the in vivo characterization, in spite of the
in vitro differences discussed above, we observed that
both BoHV-5 strains induced a similar degree of viru-
lence in cattle. Almost all animals infected with the
N569 or A663 strains showed moderate to high levels of
viral excretion confirming the virulence of the viruses
used. Individual susceptibility or technical problems dur-
ing the viral inoculation could account for the lack of
infection of the animal 191 from the N569 group.
Only one animal infected with A663 strain developed
clinical signs associated with BoHV-5 infection. This
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5 infected animals was also faced by others [29,35].
Indeed, BoHV-5 infection could induce different
degrees of disease. In this respect, Meyer et al. [26],
infected 3-month-old calves with N569 BoHV-5 strain
and the animals developed severe neurological signs.
Additionally, 6 to 8-month-old animals experimentally
infected with the A663 strain developed a moderate
BoHV-5-induced neurological disease [27]. In other
studies, experimental infections in 4 to 6-month-old
calves with BoHV-5 TX74 and EC-1 field isolates
[25,29] and Brazilian isolate SV-507 [30], have been
performed without subsequent development of neuro-
logical symptoms, although histopathological changes
in the CNS were observed. In accordance with these
studies, we did not observe neurological signs in most
of the infected animals but histopathological examina-
tion of CNS samples evidenced the development of
BoHV-5-associated encephalitis. Because the age of the
animals and the viral dose used in this study were
similar to those of previous studies in which clinical
signs were observed [26,27], the lack of neurological
signs reported here could be due to the individual
immunological status of cattle.
In addition, in agreement with results presented else-
where [36], latency was detected in all the animals
infected with A663 strain and two out of four animals
infected with N569. The negative result obtained from
trigeminal ganglion belonging to animal 199 could be
due to technical problems with conservation and/or pro-
cessing of the sample. In the case of animal 191, as dis-
cussed above, the reason could have been the lack of
infection, as all the other parameters assayed were also
negative for this animal.
At this point, we could suggest that although the
development of neurological signs is not always achieved
under experimental infection with BoHV-5, presence of
lesions in the CNS and establishment of latency are
more frequently observed.
Finally, we showed that four out of four and three out
of four animals seroconverted after infection with A663
and N569 BoHV-5 strains, respectively. In addition,
three out of four and two out of four animals infected
with A663 and N569, respectively, presented IgA muco-
sal antibodies. This constitutes the first report of IgA in
nasal secretions of animals infected with BoHV-5 and is
in agreement with previous reports showing induction
of nasal IgA in calves after infection with different
BoHV-1 strains [37]. Concerning animals 628 and 192,
the lack of IgA detection could be due to the sensitivity
of the ELISA test available. In the case of animal 191, as
discussed above, the reason could have been the lack of
infection.
Conclusions
The in vitro and in vivo properties of two strains of
BoHV-5 belonging to different subtypes were studied.
Our results show that the A663 strain used in this study
is less adapted to in vitro r e p l i c a t i o ni nM D B Kc e l l s
than the N569 strain and, although slight differences
were observed, both strains are able to induce a similar
degree of virulence in the natural host. These results
also highlight the importance of considering viral in
vitro adaptation previous to study in vivo properties and
draw general conclusions about the biology of BoHV-5.
To study the plausible differences in virulence associated
to BoHV-5 subtypes, we think it would be suitable to
use BoHV-5 field isolates without previous adaptation to
cell culture instead of viral strains with unknown his-
tory. Taking all this into consideration, further research
should be done in order to better understand the biol-
ogy of BoHV-5 and the relevance of its subtypes.
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